LC
MRNA icon

Lindbrook Capital’s Moderna MRNA Stock Holding History

Lindbrook Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$33.3K Buy
1,174
+1
+0.1% +$35 ﹤0.01% 1146
2024
Q4 		$48.8K Sell
1,173
-99
-8% -$4.73K ﹤0.01% 820
2024
Q3 		$85K Sell
1,272
-651
-34% -$59.8K 0.01% 609
2024
Q2 		$228K Buy
1,923
+448
+30% +$56.7K 0.02% 336
2024
Q1 		$157K Buy
1,475
+84
+6% +$8.47K 0.01% 415
2023
Q4 		$138K Buy
1,391
+411
+42% +$34.6K 0.01% 432
2023
Q3 		$101K Sell
980
-44
-4% -$4.91K 0.01% 468
2023
Q2 		$124K Buy
1,024
+130
+15% +$17.3K 0.01% 431
2023
Q1 		$137K Sell
894
-134
-13% -$22.1K 0.02% 397
2022
Q4 		$185K Buy
1,028
+183
+22% +$29.9K 0.02% 345
2022
Q3 		$100K Sell
845
-36
-4% -$5.46K 0.02% 428
2022
Q2 		$126K Sell
881
-1,381
-61% -$197K 0.02% 397
2022
Q1 		$390K Buy
2,262
+148
+7% +$24.9K 0.06% 189
2021
Q4 		$537K Buy
2,114
+1,698
+408% +$496K 0.08% 154
2021
Q3 		$160K Buy
416
+33
+9% +$12.2K 0.04% 186
2021
Q2 		$90K Buy
383
+24
+7% +$4.29K 0.02% 310
2021
Q1 		$47K Buy
359
+24
+7% +$3.48K 0.01% 466
2020
Q4 		$35K Buy
335
+150
+81% +$15.2K 0.01% 510
2020
Q3 		$13K Buy
185
+129
+230% +$8.99K ﹤0.01% 758
2020
Q2 		$4K Buy
56
+20
+56% +$1.09K ﹤0.01% 1182
2020
Q1 		$1K Buy
+36
New +$828 ﹤0.01% 1506

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lindbrook Capital's MRNA Position: Q1 2025 in Review

Lindbrook Capital increased its Moderna (MRNA) stake by 0.09% in Q1 2025, buying an estimated $35 and bringing the position to 1,174 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

Lindbrook Capital first reported a position in MRNA in Q1 2020 and has held it in 21 quarters since. The position peaked at $537K in Q4 2021. 694 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Lindbrook Capital held 1,174 shares of Moderna worth $33.3K as of Q1 2025.
  • Lindbrook Capital bought 1 Moderna share in Q1 2025, an estimated $35.
  • Moderna made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1146 holding.
  • Lindbrook Capital first reported a position in Moderna in Q1 2020 and has held it in 21 quarters since.
  • Lindbrook Capital's Moderna position peaked at $537K in Q4 2021.
  • 694 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.